Policy Notices

• Notice of Clarification Regarding Data Management Plan Requirement for AHRQ National Research Service Award Institutional Research Training Grant (T32) RFA-HS-22-010
  (NOT-HS-23-001)
  Agency for Healthcare Research and Quality
  

General Notices

• Notice of Correction to RFA-CA-22-013, PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)
  (NOT-CA-22-136)
  National Cancer Institute
  

• Notice of Pre-Application Webinar and FAQs for the Funding Opportunity Announcement Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) (RFA-CA-22-051)
  (NOT-CA-23-008)
  National Cancer Institute
  

• Pre-Application Webinar for NCIs FOAs on Advancing Adolescent Tobacco Cessation Intervention Research (RFA-CA-22-042, RFA-CA-22-43)
  (NOT-CA-23-009)
  National Cancer Institute
  

• Notice to Extend the Response Date for NIH Guide NOT-DE-22-019, RFI: Request for Information on Augmenting Research Training and Engaging Scientists in Dental, Oral, and Craniofacial Research Careers
  (NOT-DE-22-020)
  National Institute of Dental and Craniofacial Research
  

• Notice of Corrected Application Forms for RFA DE-23-009 Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (UG3/UH3 Clinical Trial Required)
  (NOT-DE-23-001)
  National Institute of Dental and Craniofacial Research
  

• Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-169 "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)"
  (NOT-GM-23-006)
  National Institute of General Medical Sciences
  

• Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-173 "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)"
  (NOT-GM-23-007)
  National Institute of General Medical Sciences
  

• Notice of NICHD Participation in PAR-22-242, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)"
  (NOT-HD-22-050)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NICHD Participation in PAR-22-243, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)"
  (NOT-HD-22-051)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NICHD Participation in RFA-OD-22-015, "Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education (R25 Clinical Trial Not Allowed)
  (NOT-HD-22-053)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Frequently Asked Questions (FAQs) for Multi-Omics for Health and Disease RFA-HG-22-008, RFA-HG-22-009, RFA-HG-22-010
  (NOT-HG-23-011)
  National Human Genome Research Institute
  

• Notice of Information: Research Opportunity Announcement OTA-20-014-C IMPROVE Community Implementation Program (IMPROVE-CIP) Solicitation for Research Coalitions
  (NOT-HL-22-054)
  National Heart, Lung, and Blood Institute
  

• The NIH Office of Disease Prevention (ODP) Announces the Pathways to Prevention Workshop: Identifying Risks and Interventions to Optimize Postpartum Health
  (NOT-OD-23-010)
  Office of Disease Prevention
  

• Request for Information (RFI): Soliciting Input on the Use and Reuse of Cancer Metabolomics Data
  (NOT-CA-23-007)
  National Cancer Institute
  

Notice of Changes to Funding Opportunities

• Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-21-295 NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
  (NOT-CA-22-137)
  National Cancer Institute
  

• Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-21-300 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed)
  (NOT-CA-22-140)
  National Cancer Institute
  

• Notice of Correction of Key Dates in RFA-CA-22-042, Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)
  (NOT-CA-23-003)
  National Cancer Institute
  

• Notice of Change to The Page Limits for RFA-HG-22-027, "Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)"
  (NOT-HG-23-010)
  National Human Genome Research Institute
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for the National Institute on Aging (NIA) Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Real-World Data (RWD) Platform Initiative (U54 Clinical Trial Required)
  (NOT-AG-22-044)
  National Institute on Aging
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
  (NOT-CA-23-004)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NIDA Populations of Interest
  (NOT-DA-22-084)
  National Institute on Drug Abuse
  

Funding Opportunities

• Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
  (PAR-23-021)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NCMRR Early Career Research Award (R03 Clinical Trial Optional)
  (PAR-23-029)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
  (RFA-AT-23-006)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  Application Receipt Date(s): January 10, 2023
  
  

• Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
  (RFA-DA-24-007)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 07, 2025
  
  

• Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
  (RFA-DK-22-039)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Not Applicable
  
  

• Utilizing Telomere Status to Reveal Molecular Mechanisms Underlying Susceptibility and Resiliency in Response to Environmental Exposures (R01 Clinical Trial Not Allowed)
  (RFA-ES-22-007)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): February 14, 2023